Anavex Life Sciences Corp - Company Profile
Powered by 
All the data and insights you need on Anavex Life Sciences Corp in one report.
$295
- Save hours of research time and resources with
our up-to-date Anavex Life Sciences Corp Strategy Report
- Understand Anavex Life Sciences Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Anavex Life Sciences Corp (Anavex) discovers and develops novel drugs for the treatment of diseases and disorders of CNS and various types of cancer. The company's product pipeline targets indications for the treatment of Alzheimer’s disease, epilepsy, infantile spasms, Angelman syndrome, rett syndrom Fragile X syndrome, depression, neuropathic pain, new rare disease, malignant melanoma, prostate cancer and pancreatic cancer.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Anavex R&D efforts focus on the development of novel drugs for the treatment of diseases and disorders of CNS and various types of cancer. Anavex's key technology include Sigmaceptor discovery platform. The company major Pipeline products include ANAVEX 2-73 (Blarcamesine), ANAVEX 1-41, ANAVEX 3-71 (AF710B), and ANAVEX 1066. In FY2023, the company spent US$43.717 million on its R&D activities which grew 15.3% YoY. It comprises 22 US patents, 23 US patent applications and other various PCT or ex-U.S.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer